High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease

Journal of Medical Virology

Volumn 57, Issue 4, 1999, Pages 383-389

  Drouet, Emmanuel ^a   Brousset, Pierre ^e   Fares, Fouad ^b   Icart, Josette ^c   Verniol, Cécile ^a   Meggetto, Fabienne ^e   Schlaifer, Daniel ^d   Desmorat Coat, Hélène ^d   Rigal Huguet, Françoise ^d   Niveleau, Alain ^a   Delsol, Georges ^e  

^a UNIV GRENOBLE ALPES   (France)

^b UNIVERSITÉ LYON 1   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d CHU PURPAN   (France)

^e NONE

Author keywords

EBV replication; Hodgkin's lymphoma; PCR; ZEBRA (BZLF1)

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; LATENT VIRUS INFECTION; MALE; REED STERNBERG CELL; TUMOR GROWTH; VIREMIA; VIRUS GENOME; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, VIRAL; BURKITT LYMPHOMA; DNA, VIRAL; DNA-BINDING PROTEINS; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; VIRAL PROTEINS; VIRUS REPLICATION;

DNA VIRUSES; HUMAN HERPESVIRUS 4; PHRAGMITES;

EID: 0033017530     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199904)57:4<383::AID-JMV10>3.0.CO;2-3     Document Type: Article

References (31)

1. Ambinder RF, Robertson KD, Moore SM, Yang J. 1996. Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma. Sem Cancer Biol 7:217-226.
2. Blay JY, Guimet J, Voorzanger N, Favrot MC, Drouet E. 1996. Antibodies against ZEBRA protein in patients with non Hodgkin's lymphomas and other lymphoproliferative diseases. Blood 88:381a.
3. Bogedain C, Wolf H, Modorow S, Stuber G, Jilg W. 1995. Specific cytotoxic lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J Virol 69:4872-4879.
4. Brousset P, Knecht H, Rubin B, Drouet E, Chittal S, Meggetto F, Al Saati T, Bachmann E, Denoyel GA, Sergeant A, Delsol G. 1993a. Demonstration of Epstein-Barr virus replication in Reed-Sternberg cells of Hodgkin's disease. Blood 82:872-876.
5. Brousset P, Megetto F, Chittal S, Bibeau F, Arnaud J, Rubin B, Delsol G. 1993b. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease. Lab Invest 69:483-490.
6. Brousset P, Drouet E, Schlaifert D, Icart J, Payen C, Meggetto F, Marchou B, Massip P, Delsol G. 1994. Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV. AIDS 8:583-590.
7. Chen HS, Kevan-Jah S, Sünzenich KO, Grässer FA, Müller-Lantzsch N. 1992. Expression of the Epstein-Barr Virus latent membrane protein (LMP) in insect cells and detection of antibodies in human sera against this protein. Virology 190:106-115.
8. Cheng HM, Foong YT, AbuSamah AJ, Dillner J, Sam CK, Prasad U. 1995. Linear epitopes of the replication-activator protein of Epstein-Barr Virus recognized by specific serum IgG in nasopharyngeal carcinoma. Cancer Immunol Immunother 40:251-256.
9. Chital SM, Caverivière M, Scwarting R, Gerdes J, Al Sati T, Rigal-Huguet F, Stein H, Delsol G. 1988. Monoclonal antibodies in the diagnosis of Hodgkin's disease: the search fora rational panel. Am J Surg Pathol 12:9-21.
10. Frisan T, Sjöberg J, Dolcetti R, Boiocchi M, De Re V, Carbone A, Brautbar C, Battat S, Biberfeld P, Eckman M, Öst A, Christensson B, Sundström C, Björkholm M, Pisa P, Masucci MG. 1995. Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 86:1493-1501,
11. Gan Y, Sullivan JL, Sixbey JW. 1994. Detection of cell-free Epstein Barr virus DNA in serum during acute infectious mononucleosis. J Inf Dis 170:436-439.
12. Gruus HJ, Pinto A, Duyster J, Poppema S, Herrmann F. 1997. Hodgkin's disease: a tumor with disturbed immunological pathways. Immunol Today 18:156-163.
13. Herbst H. 1996. Epstein-Barr virus in Hodgin's disease. Sem Cancer Biol 7:183-189.
14. Herbst H, Foss HD, Samol J, Araujo I, Klotzbach H. 1996. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. Blood 7:2918-2929.
15. Joab I, Nicolas JC, Schwaab G, De The G, Clausse G, Perricaudet M, Zeng Y. 1991. Detection of anti-Epstein-Barr virus transactivation (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int J Cancer 48:647-649.
16. Kelleher CA, Dreyfus DH, Jones JF, Gelfand EW. 1996. EBV infection of T cells: potential role in malignant transformation. Sem Cancer Biol 7:197-207.
17. Laroche C, Drouet E, Brousset P, Niveleau A, Pain C, Boibieux A, Biron F, Icart J, Denoyel GA. 1995. Measurement by polymerase chain reaction of the Epstein-Barr virus load in infectious mononucleosis and AIDS-related non Hodgkin's lymphomas. J Med Virol 46:66-74.
18. Martel-Renoir D, Grunewald V, Touitou R, Schwaab G, Joab I. 1995. Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies. J Gen Virol 76:1401-1408.
19. Masucci G, Mellstedt H, Masucci MG, Szigeti R, Ernberg I, Björkholm M, Tsukuda K, Henle G, Henle W, Pearson G, Holm G, Biberfeld P, Johansson, Klein G. 1984. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Cancer Res 44:1288-1300.
20. Mathew A, Cheng HM, Sam CK, Joab I, Prasad U, Cochet C. 1994. A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma. Cancer Immunol Immunother 38:68-70.
21. Miller G. 1990. The switch between latency and replication of Epstein-Barr virus. J Inf Dis 161:833-844.
22. Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Vogelman J. 1989. Hodgkin's disease and Epstein-Barr virus: altered antibody pattern before diagnosis. N Engl J Med 320:6989-6995.
23. Niedobitek G, Young LS. 1994. Epstein-Barr virus persistence and virus-associated tumours. Lancet 343:333-335.
24. Niveleau A, Drouet E, Reynaud C, Fares F, Bruno C, Pain C. 1994. Polymerase chain reaction products containing 5-methyldeoxycytidine: a microplate immunoquantitation methods. Nucleic Acids Res 22:5508-5509.
25. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. 1991. Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 337:320-322.
26. Rochford B, Mosier DE. 1995. Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes. J Virol 69:150-155.
27. Roux M, Schraven B, Roux A, Gamm H, Mertelsmann R, Meuer S. 1991. Natural inhibitors of T-cells activation in Hodgkin's disease. Blood 78:2365-2371.
28. Voorzanger N, Favrot MC, Joab I, Edelman L, Rousset F, Wijdeness J, Drouet E, Blay JY. 1994. Correlation between IL-10 expression and the presence of EBV in non-Hodgkin's lymphoma. Blood 84: 159a.
29. Weiss LM, Movahed LA, Warne RA, Sklar J. 1989. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320:502-506.
30. Yamamoto M, Kimura H, Hironaka T, Hirai K, Hasegawa, Kuzushima K, Shibata M, Morishima T. 1995. Detection and quantitation of virus DNA in plasma of patients with Epstein-Barr virus-associated diseaeses. J Clin Microbiol 33:1765-1768.
31. Yip TTC, Ngan RKC, Lau WH, Poon YF, Joab I, Cochet C, Cheng AKP. 1994. A possible prognostic role of immunoglobulin G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA in patients with nasopharyngeal carcinoma. Cancer 74:2414-2424.